Reprimo (RPRM) Is a Novel Tumor Suppressor in Pituitary Tumors and Regulates Survival, Proliferation, and Tumorigenicity

Reprimo (RPRM), initially identified as a downstream effector of p53-induced cell cycle arrest at G(2)/M, is a putative tumor suppressor silenced in some types of cancer. In microarrays, the RPRM transcript was repressed 26-fold in gonadotrope (null cell) human pituitary tumors compared with normal...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Endocrinology
Main Authors: Xu, Mei, Knox, Aaron J., Michaelis, Katherine A., Kiseljak-Vassiliades, Katja, Kleinschmidt-DeMasters, Bette K., Lillehei, Kevin O., Wierman, Margaret E.
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrine Society 2012
Assuntos:
Cancer-Oncogenes
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4714648/
https://ncbi.nlm.nih.gov/pubmed/22562171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2011-2021
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados